Autobio Diagnostics Co. Ltd

Headquarters: Zhengzhou, China

Employees: 4,544

SSE: 603658 -0.30%

Market Cap

CN¥32.43 Billion

CNY as of Jan. 1, 2024

US$4.56 Billion

history Market Cap History

Autobio Diagnostics Co. Ltd market capitalization over time

Evolution of Autobio Diagnostics Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Autobio Diagnostics Co. Ltd

Detailed Description

Autobio Diagnostics Co., Ltd. engages in the research and development, production, and distribution of clinical diagnostic products. It develops immunoassay, biochemistry, microbiology, and IVD reagents; and instruments, such as automation and semi-automation systems, as well as medical laboratory solutions. The company's immunoassay products AutoLumo A2000 Plus, an automatic Chemiluminescence immunoassay analyzer; automatic microplate chemiluminescent enzyme immunoassay; and LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Its microbiology products comprise automated blood culture systems; blood culture bottles; AUTOMIC strips; and mycoplasma IES. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is based in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Auto Industrial Co., Ltd.


"Bulls make money...
Bears make money...
Pigs get slaughtered!"

Stop guessing, unlock Financial AI.

(Don't be a pig.)

Stocks & Indices

Autobio Diagnostics Co. Ltd has the following listings and related stock indices.

Stock: SSE: 603658 wb_incandescent



No. 199, 15th Avenue

National Eco & Tech Development Area

Zhengzhou, 450016


Phone: 86 40 0056 9995

Fax: 86 371 6798 5804